NEW YORK (GenomeWeb news) – Scripps Genomic Medicine will work with Scripps Memorial Hospital La Jolla to conduct genomic studies of women for known variants of breast cancer in order to correlate the presence of variants with diagnosis of the disease, Scripps Genomic Medicine said.

The PINK study, which is funded by the Scripps Research Institute, aims to enroll 3,500 women who are receiving screenings at the Scripps Polster Breast Care Center who have had at least five years of breast imaging records available, and who will undergo a DNA analysis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A panel at the New York Times discusses anonymity and privacy of users of 23andMe's services when access to its database is offered for research.

National Institutes of Health Director Francis Collins appears before a House subcommittee to discuss his agency's budget request.

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.

The US Supreme Court has declined to review a decision involving the use of "inadvertently shed" DNA in a police investigation and subsequent conviction.